1983
DOI: 10.1001/archderm.1983.01650290066020
|View full text |Cite
|
Sign up to set email alerts
|

Long-term Risks of Psoralen and UV-A Therapy for Psoriasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

1983
1983
2002
2002

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…changes, cataract formation, alterations in the immune system etc. (3). In the present paper we describe a patient, in whom PUVA treatment induced drug fever, whereas neither 8-methoxypsoralene (8-MOP) nor UV -A irradiation gave rise to complaints.…”
mentioning
confidence: 88%
“…changes, cataract formation, alterations in the immune system etc. (3). In the present paper we describe a patient, in whom PUVA treatment induced drug fever, whereas neither 8-methoxypsoralene (8-MOP) nor UV -A irradiation gave rise to complaints.…”
mentioning
confidence: 88%
“…Ultraviolet A irradiation after oral application of 8‐methoxypsoralen (8‐MOP) led to lower UVA doses and faster improvement 4–6 . Problems inherent in systemic 8‐MOP therapy are the long‐lasting (several hours) light‐sensitivity of the patients and other systemic side‐effects such as nausea 7,8 . The side‐effects were substantially reduced when topical treatment with 8‐MOP was developed, a therapy with which the total dose of UVA can be reduced further 9–13 .…”
mentioning
confidence: 99%